Samuel Z Goldhaber Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

7/2005	Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.
8/2004	Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy.
4/2003	Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samuel Z Goldhaber Research Topics

Disease

76	Venous Thromboembolism 01/2024 - 12/2002
68	Hemorrhage 03/2024 - 04/2003
65	Pulmonary Embolism 01/2024 - 03/2002
36	Stroke (Strokes) 01/2024 - 04/2003
36	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024 - 12/2002
36	Atrial Fibrillation 01/2024 - 08/2005
32	Thrombosis (Thrombus) 03/2024 - 06/2009
21	Neoplasms (Cancer) 10/2023 - 12/2002
13	COVID-19 07/2023 - 01/2020
10	Embolism (Embolus) 01/2022 - 05/2005
10	Heart Failure 05/2021 - 04/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 07/2005
7	Hypertension (High Blood Pressure) 05/2021 - 04/2003
7	Right Ventricular Dysfunction 10/2015 - 03/2002
6	Hypotension (Low Blood Pressure) 01/2022 - 06/2003
6	Myocardial Infarction 01/2019 - 10/2002
6	Thrombocytopenia (Thrombopenia) 01/2018 - 09/2004
6	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 06/2007
5	Diabetes Mellitus 10/2023 - 01/2006
5	Drug-Related Side Effects and Adverse Reactions 01/2023 - 11/2007
5	Vascular Diseases (Vascular Disease) 01/2022 - 01/2017
4	Atherosclerosis 10/2023 - 10/2010
4	Thromboembolism 05/2021 - 09/2013
4	Critical Illness (Critically Ill) 01/2021 - 09/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2011
4	Postthrombotic Syndrome 10/2019 - 02/2012
3	Wounds and Injuries (Trauma) 10/2023 - 09/2017
3	Inflammation (Inflammations) 02/2023 - 01/2019
3	Acute Coronary Syndrome 01/2020 - 02/2013
3	Renal Insufficiency (Renal Failure) 01/2019 - 11/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 04/2003
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 11/2009
3	Chronic Renal Insufficiency 01/2019 - 07/2012
3	Obesity 09/2015 - 02/2005
3	Diabetic Nephropathies (Diabetic Nephropathy) 07/2005 - 04/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 04/2003
2	Lung Diseases (Lung Disease) 10/2023 - 08/2005
2	Varicose Veins (Varicose Vein) 10/2023 - 02/2005
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023 - 12/2016
2	Peripheral Arterial Disease 01/2022 - 12/2011
2	Dyslipidemias (Dyslipidemia) 10/2021 - 05/2021
2	Body Weight (Weight, Body) 01/2021 - 06/2004
2	Multiple Myeloma 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

67	AnticoagulantsIBA 01/2024 - 07/2004
40	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2003
24	Enoxaparin (Lovenox)FDA LinkGeneric 02/2023 - 12/2002
20	betrixabanIBA 02/2023 - 03/2014
17	Vitamin K FDA Link 01/2024 - 07/2007
17	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 12/2002
13	fibrin fragment D (D-dimer)IBA 02/2023 - 08/2002
13	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023 - 07/2004
13	Dabigatran FDA Link 01/2022 - 12/2009
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 04/2006
9	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2021 - 01/2006
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2002
7	apixabanIBA 01/2022 - 12/2011
7	RivaroxabanIBA 01/2022 - 07/2007
6	EnzymesIBA 12/2020 - 08/2002
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 07/2020
5	TroponinIBA 01/2022 - 10/2002
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 12/2020
4	Factor Xa InhibitorsIBA 05/2021 - 07/2007
4	edoxabanIBA 01/2021 - 01/2015
4	C-Reactive ProteinIBA 01/2019 - 10/2010
4	Fondaparinux (Arixtra)FDA Link 04/2013 - 12/2007
4	Irbesartan FDA LinkGeneric 05/2010 - 04/2003
3	LipidsIBA 02/2023 - 05/2021
3	CreatinineIBA 01/2021 - 04/2003
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2017 - 05/2003
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2003
3	Dalteparin (Dalteparin Sodium)FDA Link 04/2013 - 08/2004
3	Thrombin FDA Link 12/2012 - 04/2006
3	ImmunosorbentsIBA 01/2012 - 08/2002
2	Tenecteplase FDA Link 03/2024 - 04/2014
2	AlbuminsIBA 02/2023 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2021
2	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2021 - 05/2021
2	Fibric Acids (Fibrates)IBA 10/2021 - 05/2021
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2021 - 05/2021
2	HDL CholesterolIBA 10/2021 - 05/2021
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 05/2021
2	dalcetrapibIBA 10/2021 - 05/2021
2	AntithrombinsIBA 05/2021 - 03/2015

Therapy/Procedure

64	Therapeutics 03/2024 - 03/2002
28	Catheters 01/2024 - 10/2006
10	Embolectomy 01/2020 - 03/2002
7	Vena Cava Filters (Inferior Vena Cava Filter) 01/2024 - 06/2005
6	Thrombolytic Therapy 01/2017 - 08/2005
5	Contraindications 01/2024 - 05/2005
5	Central Venous Catheters 08/2019 - 09/2004
5	Compression Stockings 04/2013 - 12/2002
4	Extracorporeal Membrane Oxygenation 07/2023 - 12/2020
4	Radiotherapy 01/2017 - 11/2005
3	Medication Errors (Medication Error) 01/2023 - 11/2007
3	Orthopedic Procedures 01/2022 - 12/2007
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2017
3	Length of Stay 01/2020 - 01/2016
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2011 - 06/2004
2	Drug Tapering 01/2022 - 11/2016
2	Patient Readmission 01/2020 - 01/2018